Adicet Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017
Revenue	0	24.99	9.73	17.9	1	8.18	0
Revenue Growth (YoY)	-	156.83%	-45.65%	1699.30%	-87.84%	-	-
Gross Profit	0	24.99	9.73	17.9	1	8.18	0
Selling, General & Admin	26.53	26.3	22.22	22.76	8.69	8.43	2.04
Research & Development	106.04	71.25	48.94	34.33	23.69	14.72	16.84
Other Operating Expenses	19.46	0	0	0	0	0	0
Operating Expenses	152.04	97.54	71.16	57.09	32.38	23.15	18.88
Operating Income	-152.04	-72.55	-61.43	-39.19	-31.39	-14.96	-18.88
Interest Expense / Income	0.03	0.08	0.18	0.13	0	0	0
Other Expense / Income	-9.41	-2.84	0.52	0.17	-3.27	-5.08	14.9
Pretax Income	-142.66	-69.79	-62.12	-39.49	-28.12	-9.89	-33.78
Income Tax	0	0	-0.13	-2.82	0.02	-0.59	0
Net Income	-142.66	-69.79	-62	-36.68	-28.14	-9.3	-33.78
Shares Outstanding (Basic)	43	41	31	7	2	2	1
Shares Outstanding (Diluted)	43	41	31	7	2	2	1
Shares Change	4.78%	32.72%	322.84%	242.22%	9.86%	239.91%	-
EPS (Basic)	-3.31	-1.70	-2.00	-5.01	-13.15	-4.78	-58.94
EPS (Diluted)	-3.31	-1.70	-2.00	-5.01	-13.15	-4.78	-58.94
Free Cash Flow	-98.18	-61.55	-64.1	-42.54	-28.83	-19.06	-11.03
Free Cash Flow Per Share	-2.28	-1.50	-2.07	-5.81	-13.48	-9.79	-19.25
Gross Margin	-	100.00%	100.00%	100.00%	100.00%	100.00%	-
Operating Margin	-	-290.32%	-631.38%	-218.91%	-3154.57%	-182.91%	-
Profit Margin	-	-279.27%	-637.19%	-204.87%	-2827.94%	-113.67%	-
Free Cash Flow Margin	-	-246.29%	-658.77%	-237.62%	-2897.89%	-232.93%	-
EBITDA	-133.69	-64.7	-57.88	-37.41	-26.88	-8.67	-33.77
EBITDA Margin	-	-258.91%	-594.87%	-208.95%	-2701.61%	-105.93%	-
Depreciation & Amortization	8.94	5.01	4.07	1.95	1.24	1.22	0.01
EBIT	-142.63	-69.71	-61.95	-39.36	-28.12	-9.89	-33.78
EBIT Margin	-	-278.95%	-636.67%	-219.85%	-2826.03%	-120.87%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).